Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer

Implications for survival

Ismail Mert, Amanika Kumar, Shannon P. Sheedy, Amy L. Weaver, Michaela E. McGree, Bohyun Kim, William Arthur Cliby

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective Advanced ovarian cancer (OC) commonly spreads to cardiophrenic lymph nodes (CPLNs), and is often visible on preoperative imaging. We investigated the prognostic significance of abnormal CPLNs in OC detected by preoperative CT scans using three different definitions. Methods Patients undergoing primary debulking surgery for stage IIIC/IV with residual disease (RD) ≤ 1.0 cm and a preoperative abdominopelvic CT scan available were included. Scans were reviewed by two blinded radiologists. We characterized abnormal CPLNs using three different definitions: i) qualitative assessment score (QAS); ii) nodes > 7 mm on the short axis; or, iii) nodes ≥ 10 mm on the short axis. We compared overall survival (OS) using the log-rank test. Results Of the 253 patients (mean age 64.0 years), 136 had no gross residual disease (NGR) and 117 had RD. By the QAS definition, CPLNs were abnormal in 28 (11.1%) patients and removed in one case. Among patients with NGR, presence of abnormal CPLNs was associated with worse OS (median OS, 38.4 vs. 69.6 months, p = 0.08). We observed no association between abnormal CPLNs and OS among patients with RD (median OS, 37.5 vs. 28.5 months, p = 0.49). OS was significantly better in NGR group without abnormal CPLNs (median OS for NGR vs. RD, 69.6 vs. 28.5 months, p < 0.001); however, there was no difference in OS between patients with NGR versus RD when abnormal CPLNs were present (median OS, 38.4 vs. 37.5 months, p = 0.99). Lack of benefit from NGR when abnormal CPLNs were present was observed for all three definitions tested. Conclusion Abnormal CPLNs are an important predictor of survival in advanced stage OC. Management of abnormal CPLNs should be considered in treatment planning when the goal is NGR.

Original languageEnglish (US)
Pages (from-to)68-73
Number of pages6
JournalGynecologic Oncology
Volume148
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Ovarian Neoplasms
Lymph Nodes
Survival

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer : Implications for survival. / Mert, Ismail; Kumar, Amanika; Sheedy, Shannon P.; Weaver, Amy L.; McGree, Michaela E.; Kim, Bohyun; Cliby, William Arthur.

In: Gynecologic Oncology, Vol. 148, No. 1, 01.01.2018, p. 68-73.

Research output: Contribution to journalArticle

Mert, Ismail ; Kumar, Amanika ; Sheedy, Shannon P. ; Weaver, Amy L. ; McGree, Michaela E. ; Kim, Bohyun ; Cliby, William Arthur. / Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer : Implications for survival. In: Gynecologic Oncology. 2018 ; Vol. 148, No. 1. pp. 68-73.
@article{fb71d50860de4dc7b3b6d37ed4183aa7,
title = "Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival",
abstract = "Objective Advanced ovarian cancer (OC) commonly spreads to cardiophrenic lymph nodes (CPLNs), and is often visible on preoperative imaging. We investigated the prognostic significance of abnormal CPLNs in OC detected by preoperative CT scans using three different definitions. Methods Patients undergoing primary debulking surgery for stage IIIC/IV with residual disease (RD) ≤ 1.0 cm and a preoperative abdominopelvic CT scan available were included. Scans were reviewed by two blinded radiologists. We characterized abnormal CPLNs using three different definitions: i) qualitative assessment score (QAS); ii) nodes > 7 mm on the short axis; or, iii) nodes ≥ 10 mm on the short axis. We compared overall survival (OS) using the log-rank test. Results Of the 253 patients (mean age 64.0 years), 136 had no gross residual disease (NGR) and 117 had RD. By the QAS definition, CPLNs were abnormal in 28 (11.1{\%}) patients and removed in one case. Among patients with NGR, presence of abnormal CPLNs was associated with worse OS (median OS, 38.4 vs. 69.6 months, p = 0.08). We observed no association between abnormal CPLNs and OS among patients with RD (median OS, 37.5 vs. 28.5 months, p = 0.49). OS was significantly better in NGR group without abnormal CPLNs (median OS for NGR vs. RD, 69.6 vs. 28.5 months, p < 0.001); however, there was no difference in OS between patients with NGR versus RD when abnormal CPLNs were present (median OS, 38.4 vs. 37.5 months, p = 0.99). Lack of benefit from NGR when abnormal CPLNs were present was observed for all three definitions tested. Conclusion Abnormal CPLNs are an important predictor of survival in advanced stage OC. Management of abnormal CPLNs should be considered in treatment planning when the goal is NGR.",
author = "Ismail Mert and Amanika Kumar and Sheedy, {Shannon P.} and Weaver, {Amy L.} and McGree, {Michaela E.} and Bohyun Kim and Cliby, {William Arthur}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ygyno.2017.10.024",
language = "English (US)",
volume = "148",
pages = "68--73",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer

T2 - Implications for survival

AU - Mert, Ismail

AU - Kumar, Amanika

AU - Sheedy, Shannon P.

AU - Weaver, Amy L.

AU - McGree, Michaela E.

AU - Kim, Bohyun

AU - Cliby, William Arthur

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective Advanced ovarian cancer (OC) commonly spreads to cardiophrenic lymph nodes (CPLNs), and is often visible on preoperative imaging. We investigated the prognostic significance of abnormal CPLNs in OC detected by preoperative CT scans using three different definitions. Methods Patients undergoing primary debulking surgery for stage IIIC/IV with residual disease (RD) ≤ 1.0 cm and a preoperative abdominopelvic CT scan available were included. Scans were reviewed by two blinded radiologists. We characterized abnormal CPLNs using three different definitions: i) qualitative assessment score (QAS); ii) nodes > 7 mm on the short axis; or, iii) nodes ≥ 10 mm on the short axis. We compared overall survival (OS) using the log-rank test. Results Of the 253 patients (mean age 64.0 years), 136 had no gross residual disease (NGR) and 117 had RD. By the QAS definition, CPLNs were abnormal in 28 (11.1%) patients and removed in one case. Among patients with NGR, presence of abnormal CPLNs was associated with worse OS (median OS, 38.4 vs. 69.6 months, p = 0.08). We observed no association between abnormal CPLNs and OS among patients with RD (median OS, 37.5 vs. 28.5 months, p = 0.49). OS was significantly better in NGR group without abnormal CPLNs (median OS for NGR vs. RD, 69.6 vs. 28.5 months, p < 0.001); however, there was no difference in OS between patients with NGR versus RD when abnormal CPLNs were present (median OS, 38.4 vs. 37.5 months, p = 0.99). Lack of benefit from NGR when abnormal CPLNs were present was observed for all three definitions tested. Conclusion Abnormal CPLNs are an important predictor of survival in advanced stage OC. Management of abnormal CPLNs should be considered in treatment planning when the goal is NGR.

AB - Objective Advanced ovarian cancer (OC) commonly spreads to cardiophrenic lymph nodes (CPLNs), and is often visible on preoperative imaging. We investigated the prognostic significance of abnormal CPLNs in OC detected by preoperative CT scans using three different definitions. Methods Patients undergoing primary debulking surgery for stage IIIC/IV with residual disease (RD) ≤ 1.0 cm and a preoperative abdominopelvic CT scan available were included. Scans were reviewed by two blinded radiologists. We characterized abnormal CPLNs using three different definitions: i) qualitative assessment score (QAS); ii) nodes > 7 mm on the short axis; or, iii) nodes ≥ 10 mm on the short axis. We compared overall survival (OS) using the log-rank test. Results Of the 253 patients (mean age 64.0 years), 136 had no gross residual disease (NGR) and 117 had RD. By the QAS definition, CPLNs were abnormal in 28 (11.1%) patients and removed in one case. Among patients with NGR, presence of abnormal CPLNs was associated with worse OS (median OS, 38.4 vs. 69.6 months, p = 0.08). We observed no association between abnormal CPLNs and OS among patients with RD (median OS, 37.5 vs. 28.5 months, p = 0.49). OS was significantly better in NGR group without abnormal CPLNs (median OS for NGR vs. RD, 69.6 vs. 28.5 months, p < 0.001); however, there was no difference in OS between patients with NGR versus RD when abnormal CPLNs were present (median OS, 38.4 vs. 37.5 months, p = 0.99). Lack of benefit from NGR when abnormal CPLNs were present was observed for all three definitions tested. Conclusion Abnormal CPLNs are an important predictor of survival in advanced stage OC. Management of abnormal CPLNs should be considered in treatment planning when the goal is NGR.

UR - http://www.scopus.com/inward/record.url?scp=85033391912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033391912&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2017.10.024

DO - 10.1016/j.ygyno.2017.10.024

M3 - Article

VL - 148

SP - 68

EP - 73

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -